HomePharma Services › Trial Monitoring

Clinical trial monitoring services

Risk-based, centralised and on-site monitoring by experienced CRAs, in full or partial service models.

The problem we solve

Source data verification on everything is neither affordable nor what regulators ask for.

Since ICH E6(R2) the expectation is a risk-based approach: identify what could hurt patient safety or data integrity, monitor that closely, and stop spending visits on low-risk fields. Many studies still run the old way because nobody has time to redesign the plan.

Vakula provides the monitoring plan, the central monitoring analytics and the CRAs to execute it, as a full monitoring service or to supplement your team.

Tell us what you need

A consultant replies, not an auto-responder. Typical response inside one business day.

By submitting you agree to our Privacy Policy. We do not share your details with third parties.

What we do

Trial Monitoring capabilities

01

Risk-based monitoring

Risk assessment, key risk indicators, thresholds and a monitoring plan that targets what matters.

02

Centralised monitoring

Remote data review, statistical outlier detection and site performance dashboards.

03

On-site monitoring

Experienced CRAs for initiation, interim and close-out visits with timely, complete reports.

04

Adaptive monitoring

Visit frequency and scope adjusted as site risk changes, with documented rationale.

05

Patient-centric monitoring

Approaches that reduce site and patient burden while protecting data quality.

06

Monitoring oversight

Report review, CAPA tracking and sponsor oversight documentation.

How an engagement runs

What happens after you contact us

1

Intake call

A consultant who works in this function takes the brief: scope, systems, regulatory context, timeline and budget band. Same day where possible.

2

Proposal and people

Within a few business days you get a written scope or a shortlist of named consultants with availability and rates. No generic CVs.

3

Kick-off under a clear SOW

Deliverables, acceptance criteria, reporting cadence and escalation path are agreed in writing before work starts.

4

Delivery with oversight

A Vakula engagement lead stays accountable for quality and continuity, including cover if a consultant rolls off.

Questions

Before the first call

Can you take over monitoring mid-study?

Yes, with a documented transition plan covering site hand-over, open actions and report backlog.

Where are your CRAs?

Primarily US-based, regionally assigned to limit travel time and cost.

Do you provide the central monitoring tooling?

We work in the sponsor's or CRO's platform where one exists and can propose options where it does not.

How do you report?

A monthly monitoring dashboard and visit-report metrics agreed in the statement of work.

Start with one requirement.

Send us a role, a scope or a problem. We come back with a plan and a named consultant, not a sales deck.

Contact us+1 (848) 488-9836
Call